{"gene":"MEIS2","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":1998,"finding":"MEIS2 (MRG1) forms a trimeric complex with PBX1b and PDX1 on the B element of the pancreatic elastase I gene enhancer in acinar cells, switching PDX1 transcriptional activity from beta-cell-type activation to acinar-type; beta-cell lines lack PBX1b and MRG1, preventing trimeric complex formation.","method":"Co-immunoprecipitation, gel mobility shift assays, transcriptional reporter assays in cell lines, site-directed mutagenesis of B element","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution of trimeric complex, multiple orthogonal methods (EMSA, reporter assay, mutagenesis), clear mechanistic endpoint","pmids":["9710595"],"is_preprint":false},{"year":1998,"finding":"MEIS2 (MRG1) is a transcriptional activator; its transformation activity requires cytokine induction via the JAK/STAT signaling pathway, and mutations in the Box1 (JAK1-binding) motif or STAT3-binding region of the IL-9 receptor abolish MRG1 induction by IL-9.","method":"mRNA differential display, deletion/point mutations of IL-9 receptor domains, transfection assays, soft agar and nude mouse tumor assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis by receptor domain mutagenesis, functional transformation assays; single lab","pmids":["9811838"],"is_preprint":false},{"year":1999,"finding":"Meis2 expression restricted to proximal limb bud is essential for normal limb outgrowth; ectopic Meis2 represses distal limb genes, and BMPs together with Hoxd genes restrict Meis2 to the proximal domain, establishing a proximal-distal regulatory axis.","method":"Ectopic expression in chick limb bud, in situ hybridization, genetic epistasis with BMPs and Hoxd genes","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — loss- and gain-of-function in vivo with multiple markers, widely cited foundational study replicated in subsequent work","pmids":["10619030"],"is_preprint":false},{"year":2000,"finding":"MEIS2 isoforms (a-d) activate the D1A dopamine receptor promoter by binding the ACT element; TGIF competes with MEIS2 for the same DNA sites and represses MEIS2-induced transcription activation. Splice variant Meis2e (truncated homeodomain) cannot bind DNA or activate transcription but acts as a dominant-negative inhibitor of Meis2d.","method":"Gel mobility shift assays, transcriptional reporter assays in multiple cell lines, co-expression competition assays, in situ hybridization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — EMSA, reporter assays, dominant-negative mechanism defined by multiple splice variants across cell types","pmids":["10764806"],"is_preprint":false},{"year":2009,"finding":"Meis2 is necessary and sufficient for tectal development in chick; Meis2 competes with the Groucho co-repressor Tle4 (Grg4) for binding to Otx2, thereby relieving Otx2 transcriptional repression and restoring Otx2 activator function to specify tectal fate.","method":"In ovo electroporation (gain- and loss-of-function), Otx2-dependent reporter assay, co-immunoprecipitation/competition binding assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP competition, reporter assay, in vivo gain/loss-of-function with defined cellular phenotype","pmids":["19736326"],"is_preprint":false},{"year":2010,"finding":"The homothorax (Hth) domain of Meis2 autoinhibits its C-terminal transcriptional activation domain; binding of Pbx1 to the Hth domain partially relieves this autoinhibition. The Meis3.2 splice-equivalent deletion within the Hth domain derepresses the activation domain and weakens Pbx1 interaction.","method":"Transcriptional reporter assays, domain deletion/mutation analysis, protein interaction assays, bioinformatics","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 — domain mutagenesis with functional reporter readout; single lab","pmids":["20553494"],"is_preprint":false},{"year":2011,"finding":"Meis2 and Pbx1 physically interact with Klf4 and are co-recruited to promoter elements containing adjacent Klf4/GC-box and Meis/Pbx sites to cooperatively activate p15(Ink4a) and E-cadherin transcription; the Meis2d activation domain is required for full cooperative activation.","method":"Co-immunoprecipitation, transcriptional reporter assays, siRNA knockdown with cell cycle readout (S-phase entry), bioinformatics","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, reporter assays, KD with defined cell-cycle phenotype, multiple target genes tested","pmids":["21746878"],"is_preprint":false},{"year":2012,"finding":"Meis2 physically interacts with Pax3 and Pax7 in the tectal anlage; Meis2 acts downstream of Pax3/7, and Pax3 and Pax7 mutually regulate each other's expression and modulate Meis2 expression levels in the chick mesencephalic vesicle.","method":"In ovo electroporation (gain/loss-of-function), co-immunoprecipitation, in situ hybridization","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus genetic epistasis by electroporation; single lab","pmids":["22390724"],"is_preprint":false},{"year":2013,"finding":"Meis2 forms a complex with Pax6 and Dlx2 in adult olfactory bulb neurogenesis; Meis2 activity is cell-autonomously required for neuronal fate acquisition by SVZ-derived progenitors and for dopaminergic periglomerular neuron generation. Direct Meis2 targets identified by ChIP include doublecortin and tyrosine hydroxylase.","method":"Retroviral expression of dominant-negative forms and siRNA in vivo; chromatin immunoprecipitation (ChIP); biochemical co-immunoprecipitation of the Meis2-Pax6-Dlx2 complex","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP identifies direct targets, Co-IP defines complex, in vivo loss-of-function with defined neuronal fate phenotype","pmids":["24284204"],"is_preprint":false},{"year":2013,"finding":"Polycomb RING1B binds the Meis2 promoter and a 3'-end RING1B-binding site (RBS) to maintain repression; during midbrain development, a midbrain-specific enhancer (MBE) transiently forms a promoter-MBE-RBS tripartite interaction in a RING1-dependent manner, after which RING1B-bound RBS dissociates, leaving promoter-MBE engagement to activate Meis2 expression.","method":"Chromosome conformation capture (3C/4C), ChIP, conditional knockout mice, transgenic reporter assays","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1-2 — 3C/4C chromatin topology plus ChIP plus conditional KO with defined molecular phenotype","pmids":["24374176"],"is_preprint":false},{"year":2014,"finding":"MEIS2 is required for neuroblastoma cell survival and M-phase progression; MEIS2 transcriptionally activates the MuvB-BMYB-FOXM1 complex and directly drives FOXM1 expression to upregulate mitotic genes.","method":"siRNA depletion, ectopic overexpression, gene expression profiling, ChIP, in vitro proliferation/tumorigenicity assays","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — ChIP identifies FOXM1 as direct target, loss/gain-of-function with M-phase arrest phenotype, gene expression profiling","pmids":["25210800"],"is_preprint":false},{"year":2015,"finding":"Meis2 is required for cranial and cardiac neural crest cell development; conditional inactivation using AP2α-IRES-Cre results in persistent truncus arteriosus, craniofacial skeletal defects, and cranial nerve abnormalities, establishing Meis2 as essential for neural crest-derived tissues.","method":"Conditional knockout mice (systemic and neural crest-specific via AP2α-Cre), histology, immunohistochemistry","journal":"BMC developmental biology","confidence":"High","confidence_rationale":"Tier 2 — clean tissue-specific conditional KO with defined phenotypic readouts in multiple tissues","pmids":["26545946"],"is_preprint":false},{"year":2015,"finding":"RING1A/B (PRC1) directly binds and represses Meis1/2 in the distal forelimb bud; additional deletion of Meis2 in Ring1A/B-deficient mice partially restores distal gene expression and limb formation, placing RING1-dependent Meis2 repression as a necessary step for proximal-distal specification.","method":"Conditional double knockout mice (Ring1A/B), epistasis rescue by additional Meis2 deletion, in situ hybridization, ChIP","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 — genetic epistasis rescue experiment plus ChIP in vivo; multiple orthogonal methods","pmids":["26674308"],"is_preprint":false},{"year":2016,"finding":"MEIS2 is highly expressed in AML1-ETO-positive AML cells and is required for their growth; MEIS2 directly binds the Runt domain of AML1-ETO (shown by Co-IP), and high MEIS2 impairs repressive DNA binding of AML1-ETO, leading to increased expression of YES1.","method":"Co-immunoprecipitation (MEIS2–AML1-ETO Runt domain), shRNA knockdown, mouse leukemia model, gene expression analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — direct Co-IP of defined domain, in vivo leukemia model, loss-of-function with mechanistic consequence on AML1-ETO binding","pmids":["27346355"],"is_preprint":false},{"year":2016,"finding":"A constitutively active feedforward circuit composed of IκBα/NF-κB(p65), miR-196b-3p, Meis2, and PPP3CC drives castration-resistant prostate cancer; Meis2 is a downstream target of miR-196b-3p suppression and is part of this circuit that controls stem cell transcription factor expression.","method":"Reporter assays, miRNA target validation, knockdown experiments, mouse xenograft models","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 — pathway circuit mapped with multiple knockdowns and in vivo models; single lab","pmids":["28041912"],"is_preprint":false},{"year":2018,"finding":"MEIS2 nuclear localization in adult SVZ progenitors is regulated by arginine methylation on a conserved arginine residue; methylation impairs interaction with the nuclear export receptor CRM1 without affecting PBX1 dimerization, thereby allowing MEIS2 nuclear accumulation required for neuronal differentiation. Downregulation of EGFR signaling triggers this methylation.","method":"Mutagenesis of arginine residue, Co-IP (MEIS2–CRM1 and MEIS2–PBX1), cell fractionation, retroviral overexpression, neuronal differentiation assay","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 1-2 — post-translational modification site identified by mutagenesis, mechanistic link to nuclear export receptor binding and differentiation phenotype","pmids":["29641989"],"is_preprint":false},{"year":2018,"finding":"MEIS2 regulates endothelial-to-hematopoietic transition (EHT) from human embryonic stem cells; MEIS2 deletion suppresses hemogenic endothelial specification and EHT. TAL1 acts as a downstream gene mediating MEIS2 function during early hematopoiesis.","method":"CRISPR/Cas9 knockout in hESCs, hematopoietic differentiation assays, gene expression analysis","journal":"Stem cell research & therapy","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype; TAL1 as downstream target identified by expression analysis without direct binding assay","pmids":["30526668"],"is_preprint":false},{"year":2019,"finding":"PTBP1 upregulates the MEIS2-L splice variant (via alternative mRNA splicing) to promote bladder cancer cell migration and invasion; overexpression of MEIS2-L rescues oncogenic migration/invasion abilities and MMP9 expression after PTBP1 knockdown.","method":"siRNA knockdown, splicing variant overexpression rescue experiments, in vitro migration/invasion assays, in vivo lymph node metastasis model","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — splice variant identified as functional effector by rescue experiment; single lab","pmids":["30742945"],"is_preprint":false},{"year":2019,"finding":"MEIS2 is a substrate of the CRL4-cereblon (CRL4CRBN) E3 ubiquitin ligase; IMiDs block MEIS2 from binding CRBN, facilitating CRL4CRBN-IMiD E3-ubiquitin ligase activity and proteasome-mediated degradation of target substrates. MEIS2 also regulates Cyclin E/CCNE1 and NKG2D/DNAM-1 NK-cell ligand expression in multiple myeloma cells.","method":"siRNA knockdown, crystallographic identification of MEIS2-CRBN interaction (referenced), apoptosis and proliferation assays, BET inhibitor treatment","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 — CRBN substrate identification from crystal structure (referenced), functional siRNA data; single lab for MM-specific functional studies","pmids":["30975979"],"is_preprint":false},{"year":2019,"finding":"Silencing of both Rb1 and Meis2 by siRNA in adult cardiomyocytes promotes cell cycle re-entry; simultaneous knockdown results in increased proliferation markers (EdU, PH3, Ki67, Aurora B), reduced cardiomyocyte size, increased mononucleation, and improved cardiac function post-myocardial infarction in vivo, identifying Meis2 as a senescence-associated cell cycle inhibitor in cardiomyocytes.","method":"siRNA knockdown in isolated adult rat cardiomyocytes and hiPSC-derived cardiomyocytes, hydrogel-based in vivo delivery post-MI, immunofluorescence for proliferation markers, echocardiography","journal":"Journal of the American Heart Association","confidence":"Medium","confidence_rationale":"Tier 2 — clean loss-of-function with defined proliferation phenotype in vitro and in vivo; combinatorial knockdown complicates attribution to Meis2 alone","pmids":["31315484"],"is_preprint":false},{"year":2020,"finding":"MEIS2 directly binds chromatin of osteogenic gene loci (identified by ChIP-seq) and is required for chromatin accessibility of osteogenic genes (ATAC-seq) in the developing palate; MEIS2 physically interacts with SHOX2 and co-occupies osteogenic gene loci genome-wide. MEIS2 is required for palatal bone formation downstream of neural crest cell specification.","method":"Conditional KO mice (Wnt1-Cre), ChIP-seq, RNA-seq, ATAC-seq, Co-IP (MEIS2–SHOX2 interaction), rescue experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — genome-wide ChIP-seq, ATAC-seq, RNA-seq plus Co-IP and genetic rescue; multiple orthogonal methods in a single study","pmids":["32169905"],"is_preprint":false},{"year":2018,"finding":"Variant PRC1 incorporating PCGF3 and PCGF5 represses Meis2 in the distal forelimb bud; PcG factors and retinoic acid-related signals antagonize each other to polarize Meis2 expression along the proximal-distal axis, with PcG adjusting the threshold for RA signaling to regulate Meis2.","method":"Mouse genetics (conditional knockouts), mathematical modeling, ChIP, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and molecular dissection of PRC1 subunit specificity; modeling supplements experimental data","pmids":["30190278"],"is_preprint":false},{"year":2018,"finding":"MEIS2 nuclear localization is regulated post-translationally; arginine methylation on a conserved residue close to nested CRM1- and PBX1-binding sites controls nuclear/cytoplasmic partitioning. In the adult V-SVZ, high calpain-2 activity in stem/progenitor cells cleaves MEIS2, and reduced calpain-2 activity during neuronal differentiation stabilizes MEIS2 full-length protein.","method":"Site-directed mutagenesis of arginine, Co-IP, fractionation; calpain-2 substrate identification by in vitro cleavage and mass spectrometry (described in 2024 paper but methylation result 2018)","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 1-2 — PTM site mapped by mutagenesis, binding partner competition defined, nuclear export receptor interaction demonstrated","pmids":["29641989"],"is_preprint":false},{"year":2024,"finding":"MEIS2 is a direct substrate of the intracellular protease calpain-2 (CAPN2/CAPNS1); phosphorylation at conserved serine/threonine residues or dimerization with PBX1 reduces MEIS2 sensitivity to calpain-2 cleavage. High calpain-2 activity in adult V-SVZ stem/progenitor cells degrades MEIS2, and its decline during differentiation allows MEIS2 full-length accumulation needed for neuronal fate. Blocking calpain-2 or expressing cleavage-insensitive MEIS2 increases neuron production.","method":"In vitro protease cleavage assay with recombinant calpain-2, mutagenesis of phosphorylation/dimerization sites, Co-IP, overexpression of catalytically active CAPN2, neuronal differentiation assays in adult V-SVZ","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 — in vitro cleavage reconstitution, mutagenesis of regulatory sites, gain/loss-of-function with defined neurogenesis phenotype","pmids":["38305737"],"is_preprint":false},{"year":2022,"finding":"Meis2 directly binds the Zfp503 and Six3 promoters and is required for their expression; Dlx1/2 drives Meis2 expression in LGE progenitors at least partly through the hs599 enhancer. Loss of Meis2 blocks striatal medium spiny neuron (MSN) differentiation, reducing D1 and D2 MSNs.","method":"Conditional KO mice (Meis2 deletion), ChIP to show direct promoter binding of Zfp503 and Six3, in situ hybridization, cell counting","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrates direct promoter binding, conditional KO with defined differentiation phenotype, genetic epistasis (Dlx1/2→Meis2→Zfp503/Six3)","pmids":["35156680"],"is_preprint":false},{"year":2024,"finding":"Meis2 is specifically expressed in cutaneous low-threshold mechanoreceptors (LTMRs) in mice, dependent on target-derived signals. Conditional loss of Meis2 in LTMRs does not affect their survival or initial specification but markedly impairs end-organ innervation morphology, electrophysiological properties, and transcriptome, resulting in impaired light touch behavioral responses.","method":"Conditional KO mice (LTMR-specific), electrophysiology, electron/confocal microscopy of end-organ morphology, behavioral assays, transcriptome profiling","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — clean tissue-specific KO with multiple orthogonal readouts (morphology, electrophysiology, behavior, transcriptome)","pmids":["38386003"],"is_preprint":false},{"year":2020,"finding":"Meis2 conditional inactivation in neural crest cells (Wnt1-Cre) causes loss of Sonic hedgehog (Shh) signaling in oropharyngeal epithelium, impaired patterning of the first pharyngeal arch along lateral-medial and oral-aboral axes, and hypoplastic tongue with ectopic mandibular ossification.","method":"Conditional KO mice (Wnt1-Cre;Meis2fl/fl), in situ hybridization, immunohistochemistry for Shh pathway components and pharyngeal arch markers","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with defined pathway (Shh) and morphological phenotype; single lab","pmids":["32616504"],"is_preprint":false},{"year":2024,"finding":"Meis2 loss-of-function in the cochlea leads to a phenotype resembling Shh mutants, with loss of apically expressed cochlear genes and ectopic/extra rows of sensory hair cells; Meis2 ChIP-seq in an otic cell line identifies direct target genes involved in Shh-mediated cochlear patterning.","method":"Conditional KO mice, gene expression profiling, ChIP-seq in otic cell line","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq plus KO phenotype linking Meis2 to Shh pathway in cochlea; single lab","pmids":["39351969"],"is_preprint":false},{"year":2025,"finding":"CDK4/6 inhibition rapidly accelerates IMiD-mediated displacement of MEIS2 from CRBN and destabilizes MEIS2 protein while increasing CRBN levels, enhancing CRL4CRBN ubiquitination of IKZF3/IKZF1 for degradation. MEIS2 also promotes BCMA expression and antagonizes BCMA repression by IMiD/CELMoD, providing a survival signal in myeloma cells.","method":"Biochemical displacement assays, protein stability assays, ubiquitination assays, Co-IP, cell viability and apoptosis assays in bone marrow myeloma cells","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic biochemical assays (Co-IP, ubiquitination) with functional readouts; preprint, not yet peer-reviewed","pmids":["41279046"],"is_preprint":true},{"year":2026,"finding":"OGT mediates O-GlcNAcylation of MEIS2 at serine 237, which maintains MEIS2 protein stability by inhibiting its ubiquitination; loss of O-GlcNAc in zebrafish results in elevated cleft palate prevalence and impaired palatal bone formation. O-GlcNAcylation of MEIS2 maintains osteogenic homeostasis in palatal development.","method":"Mass spectrometry identification of O-GlcNAcylation site, site-directed mutagenesis (Ser237), ubiquitination assay, zebrafish loss-of-function, protein stability assay","journal":"International journal of oral science","confidence":"High","confidence_rationale":"Tier 1 — PTM site identified by MS and confirmed by mutagenesis, mechanistic link (O-GlcNAc inhibits ubiquitination) demonstrated biochemically with in vivo validation","pmids":["41936590"],"is_preprint":false},{"year":2025,"finding":"LncRNA RMG regulates myogenesis by modulating liquid-liquid phase separation (LLPS) of MEIS2; lnc-RMG produces miR-133a-3p which targets and inhibits MEIS2 expression, thereby inhibiting MEIS2 LLPS. This inhibition promotes TGFβR2 transcription to regulate myogenesis.","method":"lncRNA knockdown, miRNA overexpression, LLPS assay for MEIS2, luciferase reporter, qPCR/western blot, skeletal muscle regeneration model","journal":"International journal of biological macromolecules","confidence":"Low","confidence_rationale":"Tier 3 — LLPS demonstrated but MEIS2 condensate biology mechanistically underdeveloped; single study","pmids":["40252346"],"is_preprint":false}],"current_model":"MEIS2 is a TALE-homeodomain transcription factor that acts as a context-dependent transcriptional activator or repressor: it forms heterodimeric and trimeric complexes with PBX1 and HOX-class proteins (PDX1, Otx2, Pax3/7, Klf4) to regulate target gene transcription, is subject to multilayered post-translational regulation including arginine methylation (controlling nuclear export via CRM1), O-GlcNAcylation at Ser237 (stabilizing the protein by blocking ubiquitination), and calpain-2-mediated proteolytic cleavage (modulating its activity in neural stem/progenitor cells); its genomic locus is regulated by PRC1/RING1B-mediated chromatin topology and retinoic acid signaling to control proximal-distal limb patterning and midbrain specification, and it controls cell fate in multiple developmental contexts including striatal MSN differentiation (via direct transcription of Zfp503 and Six3), adult SVZ neurogenesis, neural crest-derived craniofacial and cardiac structures, and low-threshold mechanoreceptor maturation."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing MEIS2 as a transcription factor capable of trimeric complex formation with PBX and HOX-class partners answered how a TALE-homeodomain protein achieves tissue-specific transcriptional switching—here converting PDX1 from beta-cell to acinar-type activation.","evidence":"Co-IP, EMSA, and reporter assays reconstituting the MEIS2–PBX1b–PDX1 trimeric complex on the elastase I enhancer B element in pancreatic cell lines","pmids":["9710595"],"confidence":"High","gaps":["Trimeric complex demonstrated only on one enhancer element","Structural basis for partner selectivity unknown","In vivo relevance for pancreatic cell fate not tested genetically"]},{"year":1999,"claim":"Demonstrating that Meis2 expression is restricted to proximal limb and that ectopic expression represses distal limb genes established MEIS2 as a spatial determinant of proximal-distal limb identity, a role later shown to be Polycomb-regulated.","evidence":"Ectopic Meis2 expression in chick limb bud with epistasis to BMPs and Hoxd genes; in situ hybridization","pmids":["10619030"],"confidence":"High","gaps":["Downstream targets in limb not identified at this stage","Mechanism of BMP/Hoxd-mediated repression of Meis2 unclear"]},{"year":2000,"claim":"Identification of MEIS2 isoforms activating the dopamine D1A receptor promoter, and competition by TGIF on the same DNA sites, revealed a splice-variant-based regulatory logic including dominant-negative inhibition by Meis2e.","evidence":"EMSA, reporter assays across multiple cell lines, and co-expression competition assays with TGIF and Meis2e","pmids":["10764806"],"confidence":"High","gaps":["Physiological contexts where Meis2e exerts dominant-negative function in vivo uncharacterized","Full repertoire of direct DNA targets unknown"]},{"year":2009,"claim":"Showing that Meis2 competes with the Groucho co-repressor Tle4 for Otx2 binding to relieve transcriptional repression defined the mechanism by which MEIS2 specifies tectal fate—functioning not solely as a DNA-binding activator but as a co-factor competition switch.","evidence":"In ovo electroporation gain/loss-of-function, reciprocal Co-IP competition assays, Otx2-dependent reporter","pmids":["19736326"],"confidence":"High","gaps":["Whether this competition mechanism operates in mammalian midbrain unknown","Direct target genes downstream of Otx2-Meis2 in tectum not defined"]},{"year":2010,"claim":"Discovery that the Hth domain autoinhibits MEIS2's C-terminal activation domain and that PBX1 binding partially relieves this autoinhibition revealed an intrinsic regulatory switch gating transcriptional output on PBX dimerization.","evidence":"Domain deletion/mutation analysis with transcriptional reporter readouts; comparison with Meis3.2 splice variant","pmids":["20553494"],"confidence":"Medium","gaps":["Structural basis for autoinhibition not resolved","Whether other partners besides PBX1 relieve autoinhibition untested","Single-lab finding"]},{"year":2011,"claim":"Identification of a MEIS2–PBX1–KLF4 cooperative complex that activates p15(Ink4a) and E-cadherin expanded the partner repertoire beyond HOX-class proteins and linked MEIS2 to cell cycle control.","evidence":"Reciprocal Co-IP, reporter assays, siRNA knockdown with S-phase entry readout","pmids":["21746878"],"confidence":"High","gaps":["Whether this complex operates in normal development or only in tumor suppression unclear","Genome-wide target landscape of MEIS2–KLF4 not mapped"]},{"year":2013,"claim":"Two concurrent advances established (i) a Meis2–Pax6–Dlx2 complex driving adult SVZ neurogenesis with direct ChIP-validated targets (doublecortin, tyrosine hydroxylase), and (ii) a RING1B-dependent chromatin topology mechanism (promoter–enhancer–RBS tripartite loop) gating Meis2 locus activation during midbrain development.","evidence":"(i) Retroviral dominant-negative and siRNA in vivo, ChIP, Co-IP in adult SVZ; (ii) 3C/4C, ChIP, conditional KO mice, transgenic reporters","pmids":["24284204","24374176"],"confidence":"High","gaps":["Whether the Pax6–Dlx2–Meis2 complex acts identically in embryonic and adult neurogenesis untested","How RING1B release is triggered at the molecular level remains unclear"]},{"year":2014,"claim":"Demonstrating that MEIS2 directly drives FOXM1 and the MuvB–BMYB–FOXM1 mitotic gene program in neuroblastoma revealed a role for MEIS2 in M-phase progression beyond developmental transcription.","evidence":"siRNA depletion, ChIP on FOXM1 promoter, gene expression profiling, proliferation/tumorigenicity assays","pmids":["25210800"],"confidence":"High","gaps":["Whether the FOXM1 axis is relevant in normal proliferating progenitors unknown","MEIS2 co-factors in this context not identified"]},{"year":2015,"claim":"Conditional inactivation in neural crest cells causing persistent truncus arteriosus, craniofacial skeletal defects, and cranial nerve abnormalities, combined with epistasis showing RING1A/B represses Meis2 in distal limb, consolidated MEIS2 as essential for neural crest-derived tissue morphogenesis and confirmed Polycomb as a gate for Meis2 domain control in limb patterning.","evidence":"Neural crest-specific conditional KO mice (AP2α-Cre), Ring1A/B double KO with Meis2 rescue deletion, ChIP, in situ hybridization","pmids":["26545946","26674308"],"confidence":"High","gaps":["Direct target genes mediating cardiac outflow tract septation not identified","Whether MEIS2 acts cell-autonomously in all affected neural crest lineages not resolved"]},{"year":2018,"claim":"Discovery that arginine methylation on a conserved residue blocks CRM1-mediated nuclear export (without affecting PBX1 binding) introduced post-translational control of MEIS2 subcellular localization as a mechanism coupling EGFR signaling to neuronal differentiation, while variant PRC1 (PCGF3/5) was shown to set the RA-signaling threshold for Meis2 activation in limb.","evidence":"Site-directed mutagenesis, Co-IP of MEIS2–CRM1 and MEIS2–PBX1, cell fractionation, neuronal differentiation assay; PcG conditional KOs with mathematical modeling","pmids":["29641989","30190278"],"confidence":"High","gaps":["Identity of the arginine methyltransferase responsible unknown","How EGFR signaling controls methylation status not mapped"]},{"year":2019,"claim":"Identification of MEIS2 as a CRL4-CRBN E3 ligase substrate displaced by immunomodulatory drugs (IMiDs) revealed a pharmacologically relevant degradation axis, while calpain-2 cleavage sensitivity—modulated by phosphorylation and PBX1 dimerization—provided a second proteolytic layer controlling MEIS2 levels in progenitor cells.","evidence":"Crystal structure reference for CRBN interaction, siRNA in myeloma cells; in vitro calpain-2 cleavage reconstitution (reported fully in 2024), mutagenesis of phosphorylation/dimerization sites","pmids":["30975979","38305737"],"confidence":"High","gaps":["Relative contributions of CRL4-CRBN vs. calpain-2 degradation in non-cancer contexts unresolved","Calpain-2 cleavage site(s) not precisely mapped"]},{"year":2020,"claim":"Genome-wide ChIP-seq and ATAC-seq in the developing palate demonstrated that MEIS2 directly occupies and is required for chromatin accessibility at osteogenic gene loci, with SHOX2 as a physical co-occupant, providing the first genome-wide mechanistic view of MEIS2 chromatin function in craniofacial osteogenesis.","evidence":"Conditional KO mice (Wnt1-Cre), ChIP-seq, ATAC-seq, RNA-seq, Co-IP for MEIS2–SHOX2, rescue experiments","pmids":["32169905"],"confidence":"High","gaps":["Whether MEIS2 acts as a pioneer factor or requires pre-existing accessibility not tested","SHOX2 contribution to co-occupied sites not dissected genetically"]},{"year":2022,"claim":"Demonstration that Meis2 directly binds Zfp503 and Six3 promoters and is required for striatal MSN differentiation, with Dlx1/2 acting upstream via the hs599 enhancer, established a complete genetic circuit for MEIS2-dependent ventral forebrain neuronal specification.","evidence":"Conditional KO mice, ChIP at Zfp503 and Six3 promoters, in situ hybridization, cell quantification","pmids":["35156680"],"confidence":"High","gaps":["Whether MEIS2 partners (PBX, Dlx) co-occupy these promoters in striatum not tested","How D1 vs D2 MSN subtype specification diverges downstream of Meis2 unknown"]},{"year":2024,"claim":"Two studies extended MEIS2 biology to peripheral somatosensory neurons and to proteolytic regulation: Meis2 loss in LTMRs impaired end-organ innervation, electrophysiology, and touch behavior without affecting cell survival, while calpain-2 was biochemically reconstituted as a direct MEIS2 protease whose cleavage sensitivity is tuned by phosphorylation and PBX1 binding.","evidence":"LTMR-specific conditional KO with electrophysiology, EM, behavioral assays, transcriptomics; in vitro calpain-2 cleavage with recombinant proteins, mutagenesis, neuronal differentiation in adult V-SVZ","pmids":["38386003","38305737"],"confidence":"High","gaps":["Target genes controlled by MEIS2 in LTMRs not validated by ChIP","Whether calpain-2 regulation of MEIS2 operates beyond SVZ neurogenesis untested"]},{"year":2026,"claim":"O-GlcNAcylation at Ser237 was identified as a stabilizing modification that blocks MEIS2 ubiquitination, linking OGT activity to palatal bone formation and providing a third post-translational axis (alongside arginine methylation and calpain cleavage) controlling MEIS2 protein levels.","evidence":"Mass spectrometry for O-GlcNAc site, Ser237 mutagenesis, ubiquitination assay, zebrafish in vivo validation","pmids":["41936590"],"confidence":"High","gaps":["Whether Ser237 O-GlcNAcylation and CRL4-CRBN ubiquitination converge on the same lysine residues unknown","OGT upstream signals in palatal mesenchyme not identified"]},{"year":null,"claim":"Major unresolved questions include the structural basis for MEIS2 partner selectivity across developmental contexts, the identity of the arginine methyltransferase controlling nuclear export, the precise calpain-2 cleavage site(s), genome-wide target landscapes in most tissues, and whether MEIS2 liquid-liquid phase separation has functional significance in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure of MEIS2 in complex with any partner","Arginine methyltransferase identity unknown","Calpain-2 cleavage site(s) not mapped at residue level","LLPS biology based on a single low-confidence study"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,3,8,10,20,24,27]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,4,6,8,10,20,24]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[15,22]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[15,22]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,4,7,8,11,12,20,24,25,26]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,3,6,10,20,24]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[9,12,21]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[15,23,29]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[8,24,25]}],"complexes":["MEIS2–PBX1 heterodimer","MEIS2–PBX1–PDX1 trimer","MEIS2–Pax6–Dlx2 complex"],"partners":["PBX1","OTX2","PAX6","DLX2","KLF4","SHOX2","PAX3","CRBN"],"other_free_text":[]},"mechanistic_narrative":"MEIS2 is a TALE-class homeodomain transcription factor that functions as a context-dependent transcriptional activator by forming heterodimeric and trimeric complexes with PBX1, HOX-class proteins, and tissue-specific partners (Otx2, Pax3/7, Pax6, Dlx2, Klf4, SHOX2) to regulate target genes in diverse developmental and adult contexts including limb proximal-distal patterning, midbrain tectal specification, striatal medium spiny neuron differentiation, adult SVZ neurogenesis, craniofacial/cardiac neural crest morphogenesis, and low-threshold mechanoreceptor maturation [PMID:10619030, PMID:19736326, PMID:35156680, PMID:24284204, PMID:26545946, PMID:38386003]. Its transcriptional output is controlled by autoinhibition of its C-terminal activation domain by the Hth domain (relieved by PBX1 binding), competition with co-repressors such as Groucho/Tle4 and TGIF, and Polycomb (RING1B/PRC1)-dependent chromatin topology that gates locus activation in response to retinoic acid signaling [PMID:20553494, PMID:19736326, PMID:10764806, PMID:24374176, PMID:26674308]. MEIS2 protein abundance and nuclear accumulation are regulated by multilayered post-translational mechanisms: arginine methylation controls CRM1-dependent nuclear export, O-GlcNAcylation at Ser237 stabilizes MEIS2 by blocking ubiquitination, calpain-2-mediated proteolytic cleavage limits full-length protein in stem/progenitor cells, and MEIS2 serves as a substrate of the CRL4-CRBN E3 ubiquitin ligase displaced by immunomodulatory drugs [PMID:29641989, PMID:41936590, PMID:38305737, PMID:30975979]. MEIS2 directly activates genes including FOXM1, doublecortin, tyrosine hydroxylase, Zfp503, Six3, and osteogenic loci, and is required for chromatin accessibility at its target sites [PMID:25210800, PMID:24284204, PMID:35156680, PMID:32169905]."},"prefetch_data":{"uniprot":{"accession":"O14770","full_name":"Homeobox protein Meis2","aliases":["Meis1-related protein 1"],"length_aa":477,"mass_kda":51.8,"function":"Involved in transcriptional regulation. Binds to HOX or PBX proteins to form dimers, or to a DNA-bound dimer of PBX and HOX proteins and thought to have a role in stabilization of the homeoprotein-DNA complex. Isoform 3 is required for the activity of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element; MEIS2 is not involved in complex DNA-binding. Probably in complex with PBX1, is involved in transcriptional regulation by KLF4. Isoform 3 and isoform 4 can bind to a EPHA8 promoter sequence containing the DNA motif 5'-CGGTCA-3'; in cooperation with a PBX protein (such as PBX2) is proposed to be involved in the transcriptional activation of EPHA8 in the developing midbrain. May be involved in regulation of myeloid differentiation. Can bind to the DNA sequence 5'-TGACAG-3'in the activator ACT sequence of the D(1A) dopamine receptor (DRD1) promoter and activate DRD1 transcription; isoform 5 cannot activate DRD1 transcription","subcellular_location":"Nucleus; Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/O14770/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MEIS2","classification":"Not Classified","n_dependent_lines":14,"n_total_lines":1208,"dependency_fraction":0.011589403973509934},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MEIS2","total_profiled":1310},"omim":[{"mim_id":"618365","title":"ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 10; ZSCAN10","url":"https://www.omim.org/entry/618365"},{"mim_id":"616898","title":"CHROMOSOME 15q14 DELETION SYNDROME","url":"https://www.omim.org/entry/616898"},{"mim_id":"610942","title":"MICRO RNA 204; MIR204","url":"https://www.omim.org/entry/610942"},{"mim_id":"609262","title":"CEREBLON; CRBN","url":"https://www.omim.org/entry/609262"},{"mim_id":"607108","title":"PAIRED BOX GENE 6; PAX6","url":"https://www.omim.org/entry/607108"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"salivary gland","ntpm":45.2}],"url":"https://www.proteinatlas.org/search/MEIS2"},"hgnc":{"alias_symbol":["MRG1","HsT18361"],"prev_symbol":[]},"alphafold":{"accession":"O14770","domains":[{"cath_id":"1.10.10.60","chopping":"284-347","consensus_level":"high","plddt":90.9142,"start":284,"end":347},{"cath_id":"1.20.58","chopping":"68-184","consensus_level":"high","plddt":85.1072,"start":68,"end":184}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14770","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14770-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14770-F1-predicted_aligned_error_v6.png","plddt_mean":61.97},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MEIS2","jax_strain_url":"https://www.jax.org/strain/search?query=MEIS2"},"sequence":{"accession":"O14770","fasta_url":"https://rest.uniprot.org/uniprotkb/O14770.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14770/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14770"}},"corpus_meta":[{"pmid":"10619030","id":"PMC_10619030","title":"Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin.","date":"1999","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10619030","citation_count":250,"is_preprint":false},{"pmid":"20713703","id":"PMC_20713703","title":"miR-204 is required for lens and retinal development via Meis2 targeting.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20713703","citation_count":157,"is_preprint":false},{"pmid":"9710595","id":"PMC_9710595","title":"An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2).","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9710595","citation_count":146,"is_preprint":false},{"pmid":"26545946","id":"PMC_26545946","title":"Meis2 is essential for cranial and cardiac neural crest development.","date":"2015","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26545946","citation_count":103,"is_preprint":false},{"pmid":"24284204","id":"PMC_24284204","title":"Meis2 is a Pax6 co-factor in neurogenesis and dopaminergic periglomerular fate specification in the adult olfactory bulb.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24284204","citation_count":97,"is_preprint":false},{"pmid":"24374176","id":"PMC_24374176","title":"Polycomb potentiates meis2 activation in midbrain by mediating interaction of the promoter with a tissue-specific enhancer.","date":"2013","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/24374176","citation_count":95,"is_preprint":false},{"pmid":"9811838","id":"PMC_9811838","title":"MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9811838","citation_count":92,"is_preprint":false},{"pmid":"30742945","id":"PMC_30742945","title":"Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.","date":"2019","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30742945","citation_count":85,"is_preprint":false},{"pmid":"25211338","id":"PMC_25211338","title":"Regulation of arabidopsis flowering by the histone mark readers MRG1/2 via interaction with CONSTANS to modulate FT expression.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25211338","citation_count":84,"is_preprint":false},{"pmid":"9337137","id":"PMC_9337137","title":"Meis2, a novel mouse Pbx-related homeobox gene induced by retinoic acid during differentiation of P19 embryonal carcinoma cells.","date":"1997","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9337137","citation_count":84,"is_preprint":false},{"pmid":"10764806","id":"PMC_10764806","title":"Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10764806","citation_count":70,"is_preprint":false},{"pmid":"19736326","id":"PMC_19736326","title":"Meis2 competes with the Groucho co-repressor Tle4 for binding to Otx2 and specifies tectal fate without induction of a secondary midbrain-hindbrain boundary organizer.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19736326","citation_count":68,"is_preprint":false},{"pmid":"29716922","id":"PMC_29716922","title":"MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.","date":"2018","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/29716922","citation_count":62,"is_preprint":false},{"pmid":"31315484","id":"PMC_31315484","title":"Inhibition of Senescence-Associated Genes Rb1 and Meis2 in Adult Cardiomyocytes Results in Cell Cycle Reentry and Cardiac Repair Post-Myocardial Infarction.","date":"2019","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/31315484","citation_count":59,"is_preprint":false},{"pmid":"18461604","id":"PMC_18461604","title":"Expression of FOXP2 in the developing monkey forebrain: comparison with the expression of the genes FOXP1, PBX3, and MEIS2.","date":"2008","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18461604","citation_count":59,"is_preprint":false},{"pmid":"9337138","id":"PMC_9337138","title":"Expression of Meis2, a Knotted-related murine homeobox gene, indicates a role in the differentiation of the forebrain and the somitic mesoderm.","date":"1997","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9337138","citation_count":58,"is_preprint":false},{"pmid":"28041912","id":"PMC_28041912","title":"A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28041912","citation_count":56,"is_preprint":false},{"pmid":"9434189","id":"PMC_9434189","title":"MSG1 and its related protein MRG1 share a transcription activating domain.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9434189","citation_count":55,"is_preprint":false},{"pmid":"25210800","id":"PMC_25210800","title":"MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25210800","citation_count":51,"is_preprint":false},{"pmid":"25712757","id":"PMC_25712757","title":"MEIS2 involvement in cardiac development, cleft palate, and intellectual disability.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25712757","citation_count":50,"is_preprint":false},{"pmid":"10552932","id":"PMC_10552932","title":"Molecular cloning and chromosomal localization of the human CITED2 gene encoding p35srj/Mrg1.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10552932","citation_count":47,"is_preprint":false},{"pmid":"22390724","id":"PMC_22390724","title":"Genetic and physical interaction of Meis2, Pax3 and Pax7 during dorsal midbrain development.","date":"2012","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22390724","citation_count":46,"is_preprint":false},{"pmid":"23541832","id":"PMC_23541832","title":"FOXC1 in human trabecular meshwork cells is involved in regulatory pathway that includes miR-204, MEIS2, and ITGβ1.","date":"2013","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/23541832","citation_count":43,"is_preprint":false},{"pmid":"21746878","id":"PMC_21746878","title":"Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21746878","citation_count":42,"is_preprint":false},{"pmid":"17215300","id":"PMC_17215300","title":"MRG-1, an autosome-associated protein, silences X-linked genes and protects germline immortality in Caenorhabditis elegans.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17215300","citation_count":42,"is_preprint":false},{"pmid":"27346355","id":"PMC_27346355","title":"MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27346355","citation_count":39,"is_preprint":false},{"pmid":"24678003","id":"PMC_24678003","title":"Haploinsufficiency of MEIS2 is associated with orofacial clefting and learning disability.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/24678003","citation_count":38,"is_preprint":false},{"pmid":"30526668","id":"PMC_30526668","title":"MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1.","date":"2018","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30526668","citation_count":35,"is_preprint":false},{"pmid":"27225850","id":"PMC_27225850","title":"De novo MEIS2 mutation causes syndromic developmental delay with persistent gastro-esophageal reflux.","date":"2016","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27225850","citation_count":34,"is_preprint":false},{"pmid":"32315442","id":"PMC_32315442","title":"MRG1/2 histone methylation readers and HD2C histone deacetylase associate in repression of the florigen gene FT to set a proper flowering time in response to day-length changes.","date":"2020","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/32315442","citation_count":33,"is_preprint":false},{"pmid":"30735726","id":"PMC_30735726","title":"MEIS2 gene is responsible for intellectual disability, cardiac defects and a distinct facial phenotype.","date":"2019","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30735726","citation_count":33,"is_preprint":false},{"pmid":"30291340","id":"PMC_30291340","title":"Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability.","date":"2018","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/30291340","citation_count":33,"is_preprint":false},{"pmid":"11287203","id":"PMC_11287203","title":"Cloning and developmental expression of a zebrafish meis2 homeobox gene.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11287203","citation_count":33,"is_preprint":false},{"pmid":"35156680","id":"PMC_35156680","title":"Dlx1/2-dependent expression of Meis2 promotes neuronal fate determination in the mammalian striatum.","date":"2022","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35156680","citation_count":31,"is_preprint":false},{"pmid":"30859572","id":"PMC_30859572","title":"Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30859572","citation_count":30,"is_preprint":false},{"pmid":"12175490","id":"PMC_12175490","title":"MRG-1, a mortality factor-related chromodomain protein, is required maternally for primordial germ cells to initiate mitotic proliferation in C. elegans.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/12175490","citation_count":30,"is_preprint":false},{"pmid":"17729288","id":"PMC_17729288","title":"Expression of the homeodomain transcription factor Meis2 in the embryonic and postnatal retina.","date":"2007","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17729288","citation_count":29,"is_preprint":false},{"pmid":"30055086","id":"PMC_30055086","title":"De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30055086","citation_count":29,"is_preprint":false},{"pmid":"20523026","id":"PMC_20523026","title":"Spatiotemporal distribution of PAX6 and MEIS2 expression and total cell numbers in the ganglionic eminence in the early developing human forebrain.","date":"2010","source":"Developmental neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20523026","citation_count":29,"is_preprint":false},{"pmid":"26512644","id":"PMC_26512644","title":"miR-134 Modulates the Proliferation of Human Cardiomyocyte Progenitor Cells by Targeting Meis2.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26512644","citation_count":27,"is_preprint":false},{"pmid":"25564623","id":"PMC_25564623","title":"Proteasome regulation of the chromodomain protein MRG-1 controls the balance between proliferative fate and differentiation in the C. elegans germ line.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25564623","citation_count":27,"is_preprint":false},{"pmid":"31115559","id":"PMC_31115559","title":"MEIS2 promotes cell migration and invasion in colorectal cancer.","date":"2019","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/31115559","citation_count":24,"is_preprint":false},{"pmid":"22172672","id":"PMC_22172672","title":"The chromodomain protein MRG-1 facilitates SC-independent homologous pairing during meiosis in Caenorhabditis elegans.","date":"2011","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/22172672","citation_count":24,"is_preprint":false},{"pmid":"11114295","id":"PMC_11114295","title":"MRG1 expression in fibroblasts is regulated by Sp1/Sp3 and an Ets transcription factor.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11114295","citation_count":23,"is_preprint":false},{"pmid":"32169905","id":"PMC_32169905","title":"The transcriptional regulator MEIS2 sets up the ground state for palatal osteogenesis in mice.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32169905","citation_count":22,"is_preprint":false},{"pmid":"28960191","id":"PMC_28960191","title":"Meis2 as a critical player in MN1-induced leukemia.","date":"2017","source":"Blood cancer journal","url":"https://pubmed.ncbi.nlm.nih.gov/28960191","citation_count":21,"is_preprint":false},{"pmid":"36113831","id":"PMC_36113831","title":"IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.","date":"2022","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36113831","citation_count":20,"is_preprint":false},{"pmid":"34638267","id":"PMC_34638267","title":"MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34638267","citation_count":20,"is_preprint":false},{"pmid":"32324922","id":"PMC_32324922","title":"The histone methylation readers MRG1/MRG2 and the histone chaperones NRP1/NRP2 associate in fine-tuning Arabidopsis flowering time.","date":"2020","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32324922","citation_count":19,"is_preprint":false},{"pmid":"20553494","id":"PMC_20553494","title":"An autoinhibitory effect of the homothorax domain of Meis2.","date":"2010","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/20553494","citation_count":19,"is_preprint":false},{"pmid":"32616504","id":"PMC_32616504","title":"Neural crest cells require Meis2 for patterning the mandibular arch via the Sonic hedgehog pathway.","date":"2020","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/32616504","citation_count":18,"is_preprint":false},{"pmid":"25166052","id":"PMC_25166052","title":"Differential expression of Meis2, Mab21l2 and Tbx3 during limb development associated with diversification of limb morphology in mammals.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25166052","citation_count":17,"is_preprint":false},{"pmid":"11731263","id":"PMC_11731263","title":"Cloning and expression of the TALE superclass homeobox Meis2 gene during zebrafish embryonic development.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11731263","citation_count":17,"is_preprint":false},{"pmid":"29641989","id":"PMC_29641989","title":"Arginine Methylation Regulates MEIS2 Nuclear Localization to Promote Neuronal Differentiation of Adult SVZ Progenitors.","date":"2018","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29641989","citation_count":16,"is_preprint":false},{"pmid":"38308844","id":"PMC_38308844","title":"Histone methylation readers MRG1/2 interact with PIF4 to promote thermomorphogenesis in Arabidopsis.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/38308844","citation_count":15,"is_preprint":false},{"pmid":"36840946","id":"PMC_36840946","title":"CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis.","date":"2023","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/36840946","citation_count":15,"is_preprint":false},{"pmid":"30190278","id":"PMC_30190278","title":"Variant PRC1 competes with retinoic acid-related signals to repress Meis2 in the mouse distal forelimb bud.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30190278","citation_count":15,"is_preprint":false},{"pmid":"33975520","id":"PMC_33975520","title":"Meis homeobox 2 (MEIS2) inhibits the proliferation and promotes apoptosis of thyroid cancer cell and through the NF-κB signaling pathway.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/33975520","citation_count":15,"is_preprint":false},{"pmid":"30975979","id":"PMC_30975979","title":"The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30975979","citation_count":15,"is_preprint":false},{"pmid":"26674308","id":"PMC_26674308","title":"RING1 proteins contribute to early proximal-distal specification of the forelimb bud by restricting Meis2 expression.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26674308","citation_count":14,"is_preprint":false},{"pmid":"34053876","id":"PMC_34053876","title":"LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628-5p/MEIS2 axis to activate the Notch pathway.","date":"2021","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/34053876","citation_count":14,"is_preprint":false},{"pmid":"15972600","id":"PMC_15972600","title":"Functional analysis of MRG-1: the ortholog of human MRG15 in Caenorhabditis elegans.","date":"2005","source":"The journals of gerontology. Series A, Biological sciences and medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15972600","citation_count":14,"is_preprint":false},{"pmid":"31640805","id":"PMC_31640805","title":"Epigenetic silencing of MEIS2 in prostate cancer recurrence.","date":"2019","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/31640805","citation_count":12,"is_preprint":false},{"pmid":"35416122","id":"PMC_35416122","title":"MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35416122","citation_count":12,"is_preprint":false},{"pmid":"34124068","id":"PMC_34124068","title":"Meis2 Is Required for Inner Ear Formation and Proper Morphogenesis of the Cochlea.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34124068","citation_count":10,"is_preprint":false},{"pmid":"22212480","id":"PMC_22212480","title":"MRG-1 is required for genomic integrity in Caenorhabditis elegans germ cells.","date":"2012","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/22212480","citation_count":10,"is_preprint":false},{"pmid":"25861444","id":"PMC_25861444","title":"Retinoic acid-independent expression of Meis2 during autopod patterning in the developing bat and mouse limb.","date":"2015","source":"EvoDevo","url":"https://pubmed.ncbi.nlm.nih.gov/25861444","citation_count":9,"is_preprint":false},{"pmid":"33427397","id":"PMC_33427397","title":"Intellectual disability associated with craniofacial dysmorphism, cleft palate, and congenital heart defect due to a de novo MEIS2 mutation: A clinical longitudinal study.","date":"2021","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/33427397","citation_count":9,"is_preprint":false},{"pmid":"26221261","id":"PMC_26221261","title":"Depletion of MEIS2 inhibits osteogenic differentiation potential of human dental stem cells.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26221261","citation_count":8,"is_preprint":false},{"pmid":"36870415","id":"PMC_36870415","title":"Histone methylation readers MRG1/MRG2 interact with the transcription factor TCP14 to positively modulate cytokinin sensitivity in Arabidopsis.","date":"2023","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/36870415","citation_count":7,"is_preprint":false},{"pmid":"33091211","id":"PMC_33091211","title":"MEIS2 sequence variant in a child with intellectual disability and cardiac defects: Expansion of the phenotypic spectrum and documentation of low-level mosaicism in an unaffected parent.","date":"2020","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/33091211","citation_count":7,"is_preprint":false},{"pmid":"33722742","id":"PMC_33722742","title":"A novel MEIS2 mutation explains the complex phenotype in a boy with a typical NF1 microdeletion syndrome.","date":"2021","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33722742","citation_count":7,"is_preprint":false},{"pmid":"38386003","id":"PMC_38386003","title":"Touch receptor end-organ innervation and function require sensory neuron expression of the transcription factor Meis2.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/38386003","citation_count":7,"is_preprint":false},{"pmid":"30594396","id":"PMC_30594396","title":"Meis2 represses the osteoblastic transdifferentiation of aortic valve interstitial cells through the Notch1/Twist1 pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30594396","citation_count":6,"is_preprint":false},{"pmid":"36753664","id":"PMC_36753664","title":"ERN1 dependent impact of glucose and glutamine deprivations on PBX3, PBXIP1, PAX6, MEIS1, and MEIS2 genes expression in U87 glioma cells.","date":"2023","source":"Endocrine regulations","url":"https://pubmed.ncbi.nlm.nih.gov/36753664","citation_count":6,"is_preprint":false},{"pmid":"35698829","id":"PMC_35698829","title":"SUMOylation of the chromodomain factor MRG-1 in C. elegans affects chromatin-regulatory dynamics.","date":"2022","source":"BioTechniques","url":"https://pubmed.ncbi.nlm.nih.gov/35698829","citation_count":6,"is_preprint":false},{"pmid":"36418415","id":"PMC_36418415","title":"The autism-associated Meis2 gene is necessary for cardiac baroreflex regulation in mice.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36418415","citation_count":5,"is_preprint":false},{"pmid":"7874742","id":"PMC_7874742","title":"MRG1-1, a dominant allele that confers methomyl resistance in yeast expressing the cytoplasmic male sterility T-urf13 gene from maize.","date":"1994","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7874742","citation_count":5,"is_preprint":false},{"pmid":"38711262","id":"PMC_38711262","title":"MEIS2 suppresses breast cancer development by downregulating IL10.","date":"2024","source":"Cancer reports (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/38711262","citation_count":5,"is_preprint":false},{"pmid":"38305737","id":"PMC_38305737","title":"The neuronal transcription factor MEIS2 is a calpain-2 protease target.","date":"2024","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/38305737","citation_count":4,"is_preprint":false},{"pmid":"40252346","id":"PMC_40252346","title":"LncRNA RMG controls liquid-liquid phase separation of MEIS2 to regulate myogenesis.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40252346","citation_count":4,"is_preprint":false},{"pmid":"34930369","id":"PMC_34930369","title":"MEIS2 (15q14) gene deletions in siblings with mild developmental phenotypes and bifid uvula: documentation of mosaicism in an unaffected parent.","date":"2021","source":"Molecular cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/34930369","citation_count":4,"is_preprint":false},{"pmid":"19188860","id":"PMC_19188860","title":"Sonic hedgehog signaling in the chick retina accelerates Meis2 downregulation simultaneously with retinal ganglion cell genesis.","date":"2009","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/19188860","citation_count":4,"is_preprint":false},{"pmid":"37660994","id":"PMC_37660994","title":"LINC-PINT suppresses breast cancer cell proliferation and migration via MEIS2/PPP3CC/NF-κB pathway by sponging miR-576-5p.","date":"2023","source":"The American journal of the medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37660994","citation_count":4,"is_preprint":false},{"pmid":"36247013","id":"PMC_36247013","title":"Meis2 controls skeletal formation in the hyoid region.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36247013","citation_count":4,"is_preprint":false},{"pmid":"30929290","id":"PMC_30929290","title":"MRG-1 is required for both chromatin-based transcriptional silencing and genomic integrity of primordial germ cells in Caenorhabditis elegans.","date":"2019","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/30929290","citation_count":3,"is_preprint":false},{"pmid":"39351969","id":"PMC_39351969","title":"Analysis of Meis2 knockout mice reveals Sonic hedgehog-mediated patterning of the cochlear duct.","date":"2024","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/39351969","citation_count":2,"is_preprint":false},{"pmid":"40183774","id":"PMC_40183774","title":"Mesenchymal Meis2 controls whisker development independently from trigeminal sensory innervation.","date":"2025","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/40183774","citation_count":2,"is_preprint":false},{"pmid":"40249092","id":"PMC_40249092","title":"High-Grade Uterine Sarcoma: First Report of a MEIS2::FOXO4 Fusion.","date":"2025","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40249092","citation_count":1,"is_preprint":false},{"pmid":"41313264","id":"PMC_41313264","title":"Comparative distribution of the hypothalamic neurons activated during wakefulness and paradoxical (REM) sleep using male TRAP2-red mice: contribution of orexin, MCH, Lhx6, and a new marker Meis2.","date":"2026","source":"Sleep","url":"https://pubmed.ncbi.nlm.nih.gov/41313264","citation_count":1,"is_preprint":false},{"pmid":"39789493","id":"PMC_39789493","title":"Long read Nanopore sequencing identifies precise breakpoints of a de novo paracentric inversion that disrupt the MEIS2 gene in a Chinese girl with syndromic developmental delay.","date":"2025","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/39789493","citation_count":1,"is_preprint":false},{"pmid":"26537333","id":"PMC_26537333","title":"Restricted distribution of mrg-1 mRNA in C. elegans primordial germ cells through germ granule-independent regulation.","date":"2015","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/26537333","citation_count":1,"is_preprint":false},{"pmid":"7797428","id":"PMC_7797428","title":"Detection of a glycosphingolipid antigen in bladder cancer cells with monoclonal antibody MRG-1.","date":"1995","source":"The Histochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/7797428","citation_count":1,"is_preprint":false},{"pmid":"32138576","id":"PMC_32138576","title":"Placental Expression of the Forelimb Patterning Transcription Factor MEIS2 in Trisomy 15.","date":"2020","source":"Fetal and pediatric pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32138576","citation_count":0,"is_preprint":false},{"pmid":"41031828","id":"PMC_41031828","title":"MEIS2 Modulates Oxidative Phosphorylation and ROS Generation to Affect CD8+ T Cell Antitumor Immunity in Prostate Cancer.","date":"2025","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/41031828","citation_count":0,"is_preprint":false},{"pmid":"39639090","id":"PMC_39639090","title":"Multi-omics analysis detail a submicroscopic inv(15)(q14q15) generating fusion transcripts and MEIS2 and NUSAP1 haploinsufficiency.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39639090","citation_count":0,"is_preprint":false},{"pmid":"41080700","id":"PMC_41080700","title":"Functional analysis of MEIS2 splice site variant c.438 + 1G>T in a congenital heart patient.","date":"2025","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41080700","citation_count":0,"is_preprint":false},{"pmid":"41279046","id":"PMC_41279046","title":"CDK4/6 Inhibition Reverses MEIS2 Suppression of CRL4 CRBN to Enhance Immunomodulatory Drug Therapy in Multiple Myeloma.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41279046","citation_count":0,"is_preprint":false},{"pmid":"41936590","id":"PMC_41936590","title":"OGT mediates O-GlcNAcylation of MEIS2 and affects palatal osteogenic development.","date":"2026","source":"International journal of oral science","url":"https://pubmed.ncbi.nlm.nih.gov/41936590","citation_count":0,"is_preprint":false},{"pmid":"39776641","id":"PMC_39776641","title":"Cleft palate, congenital heart disease, and developmental delay involving MEIS2 heterozygous mutations found in the patient with attention deficit hyperactivity disorder: a case report.","date":"2024","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/39776641","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48090,"output_tokens":7730,"usd":0.13011},"stage2":{"model":"claude-opus-4-6","input_tokens":11454,"output_tokens":4539,"usd":0.256117},"total_usd":0.386227,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"MEIS2 (MRG1) forms a trimeric complex with PBX1b and PDX1 on the B element of the pancreatic elastase I gene enhancer in acinar cells, switching PDX1 transcriptional activity from beta-cell-type activation to acinar-type; beta-cell lines lack PBX1b and MRG1, preventing trimeric complex formation.\",\n      \"method\": \"Co-immunoprecipitation, gel mobility shift assays, transcriptional reporter assays in cell lines, site-directed mutagenesis of B element\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution of trimeric complex, multiple orthogonal methods (EMSA, reporter assay, mutagenesis), clear mechanistic endpoint\",\n      \"pmids\": [\"9710595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MEIS2 (MRG1) is a transcriptional activator; its transformation activity requires cytokine induction via the JAK/STAT signaling pathway, and mutations in the Box1 (JAK1-binding) motif or STAT3-binding region of the IL-9 receptor abolish MRG1 induction by IL-9.\",\n      \"method\": \"mRNA differential display, deletion/point mutations of IL-9 receptor domains, transfection assays, soft agar and nude mouse tumor assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis by receptor domain mutagenesis, functional transformation assays; single lab\",\n      \"pmids\": [\"9811838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Meis2 expression restricted to proximal limb bud is essential for normal limb outgrowth; ectopic Meis2 represses distal limb genes, and BMPs together with Hoxd genes restrict Meis2 to the proximal domain, establishing a proximal-distal regulatory axis.\",\n      \"method\": \"Ectopic expression in chick limb bud, in situ hybridization, genetic epistasis with BMPs and Hoxd genes\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss- and gain-of-function in vivo with multiple markers, widely cited foundational study replicated in subsequent work\",\n      \"pmids\": [\"10619030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MEIS2 isoforms (a-d) activate the D1A dopamine receptor promoter by binding the ACT element; TGIF competes with MEIS2 for the same DNA sites and represses MEIS2-induced transcription activation. Splice variant Meis2e (truncated homeodomain) cannot bind DNA or activate transcription but acts as a dominant-negative inhibitor of Meis2d.\",\n      \"method\": \"Gel mobility shift assays, transcriptional reporter assays in multiple cell lines, co-expression competition assays, in situ hybridization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — EMSA, reporter assays, dominant-negative mechanism defined by multiple splice variants across cell types\",\n      \"pmids\": [\"10764806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Meis2 is necessary and sufficient for tectal development in chick; Meis2 competes with the Groucho co-repressor Tle4 (Grg4) for binding to Otx2, thereby relieving Otx2 transcriptional repression and restoring Otx2 activator function to specify tectal fate.\",\n      \"method\": \"In ovo electroporation (gain- and loss-of-function), Otx2-dependent reporter assay, co-immunoprecipitation/competition binding assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP competition, reporter assay, in vivo gain/loss-of-function with defined cellular phenotype\",\n      \"pmids\": [\"19736326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The homothorax (Hth) domain of Meis2 autoinhibits its C-terminal transcriptional activation domain; binding of Pbx1 to the Hth domain partially relieves this autoinhibition. The Meis3.2 splice-equivalent deletion within the Hth domain derepresses the activation domain and weakens Pbx1 interaction.\",\n      \"method\": \"Transcriptional reporter assays, domain deletion/mutation analysis, protein interaction assays, bioinformatics\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain mutagenesis with functional reporter readout; single lab\",\n      \"pmids\": [\"20553494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Meis2 and Pbx1 physically interact with Klf4 and are co-recruited to promoter elements containing adjacent Klf4/GC-box and Meis/Pbx sites to cooperatively activate p15(Ink4a) and E-cadherin transcription; the Meis2d activation domain is required for full cooperative activation.\",\n      \"method\": \"Co-immunoprecipitation, transcriptional reporter assays, siRNA knockdown with cell cycle readout (S-phase entry), bioinformatics\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, reporter assays, KD with defined cell-cycle phenotype, multiple target genes tested\",\n      \"pmids\": [\"21746878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Meis2 physically interacts with Pax3 and Pax7 in the tectal anlage; Meis2 acts downstream of Pax3/7, and Pax3 and Pax7 mutually regulate each other's expression and modulate Meis2 expression levels in the chick mesencephalic vesicle.\",\n      \"method\": \"In ovo electroporation (gain/loss-of-function), co-immunoprecipitation, in situ hybridization\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus genetic epistasis by electroporation; single lab\",\n      \"pmids\": [\"22390724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Meis2 forms a complex with Pax6 and Dlx2 in adult olfactory bulb neurogenesis; Meis2 activity is cell-autonomously required for neuronal fate acquisition by SVZ-derived progenitors and for dopaminergic periglomerular neuron generation. Direct Meis2 targets identified by ChIP include doublecortin and tyrosine hydroxylase.\",\n      \"method\": \"Retroviral expression of dominant-negative forms and siRNA in vivo; chromatin immunoprecipitation (ChIP); biochemical co-immunoprecipitation of the Meis2-Pax6-Dlx2 complex\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP identifies direct targets, Co-IP defines complex, in vivo loss-of-function with defined neuronal fate phenotype\",\n      \"pmids\": [\"24284204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Polycomb RING1B binds the Meis2 promoter and a 3'-end RING1B-binding site (RBS) to maintain repression; during midbrain development, a midbrain-specific enhancer (MBE) transiently forms a promoter-MBE-RBS tripartite interaction in a RING1-dependent manner, after which RING1B-bound RBS dissociates, leaving promoter-MBE engagement to activate Meis2 expression.\",\n      \"method\": \"Chromosome conformation capture (3C/4C), ChIP, conditional knockout mice, transgenic reporter assays\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — 3C/4C chromatin topology plus ChIP plus conditional KO with defined molecular phenotype\",\n      \"pmids\": [\"24374176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MEIS2 is required for neuroblastoma cell survival and M-phase progression; MEIS2 transcriptionally activates the MuvB-BMYB-FOXM1 complex and directly drives FOXM1 expression to upregulate mitotic genes.\",\n      \"method\": \"siRNA depletion, ectopic overexpression, gene expression profiling, ChIP, in vitro proliferation/tumorigenicity assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP identifies FOXM1 as direct target, loss/gain-of-function with M-phase arrest phenotype, gene expression profiling\",\n      \"pmids\": [\"25210800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Meis2 is required for cranial and cardiac neural crest cell development; conditional inactivation using AP2α-IRES-Cre results in persistent truncus arteriosus, craniofacial skeletal defects, and cranial nerve abnormalities, establishing Meis2 as essential for neural crest-derived tissues.\",\n      \"method\": \"Conditional knockout mice (systemic and neural crest-specific via AP2α-Cre), histology, immunohistochemistry\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean tissue-specific conditional KO with defined phenotypic readouts in multiple tissues\",\n      \"pmids\": [\"26545946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RING1A/B (PRC1) directly binds and represses Meis1/2 in the distal forelimb bud; additional deletion of Meis2 in Ring1A/B-deficient mice partially restores distal gene expression and limb formation, placing RING1-dependent Meis2 repression as a necessary step for proximal-distal specification.\",\n      \"method\": \"Conditional double knockout mice (Ring1A/B), epistasis rescue by additional Meis2 deletion, in situ hybridization, ChIP\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic epistasis rescue experiment plus ChIP in vivo; multiple orthogonal methods\",\n      \"pmids\": [\"26674308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MEIS2 is highly expressed in AML1-ETO-positive AML cells and is required for their growth; MEIS2 directly binds the Runt domain of AML1-ETO (shown by Co-IP), and high MEIS2 impairs repressive DNA binding of AML1-ETO, leading to increased expression of YES1.\",\n      \"method\": \"Co-immunoprecipitation (MEIS2–AML1-ETO Runt domain), shRNA knockdown, mouse leukemia model, gene expression analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct Co-IP of defined domain, in vivo leukemia model, loss-of-function with mechanistic consequence on AML1-ETO binding\",\n      \"pmids\": [\"27346355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A constitutively active feedforward circuit composed of IκBα/NF-κB(p65), miR-196b-3p, Meis2, and PPP3CC drives castration-resistant prostate cancer; Meis2 is a downstream target of miR-196b-3p suppression and is part of this circuit that controls stem cell transcription factor expression.\",\n      \"method\": \"Reporter assays, miRNA target validation, knockdown experiments, mouse xenograft models\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway circuit mapped with multiple knockdowns and in vivo models; single lab\",\n      \"pmids\": [\"28041912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MEIS2 nuclear localization in adult SVZ progenitors is regulated by arginine methylation on a conserved arginine residue; methylation impairs interaction with the nuclear export receptor CRM1 without affecting PBX1 dimerization, thereby allowing MEIS2 nuclear accumulation required for neuronal differentiation. Downregulation of EGFR signaling triggers this methylation.\",\n      \"method\": \"Mutagenesis of arginine residue, Co-IP (MEIS2–CRM1 and MEIS2–PBX1), cell fractionation, retroviral overexpression, neuronal differentiation assay\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — post-translational modification site identified by mutagenesis, mechanistic link to nuclear export receptor binding and differentiation phenotype\",\n      \"pmids\": [\"29641989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MEIS2 regulates endothelial-to-hematopoietic transition (EHT) from human embryonic stem cells; MEIS2 deletion suppresses hemogenic endothelial specification and EHT. TAL1 acts as a downstream gene mediating MEIS2 function during early hematopoiesis.\",\n      \"method\": \"CRISPR/Cas9 knockout in hESCs, hematopoietic differentiation assays, gene expression analysis\",\n      \"journal\": \"Stem cell research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype; TAL1 as downstream target identified by expression analysis without direct binding assay\",\n      \"pmids\": [\"30526668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PTBP1 upregulates the MEIS2-L splice variant (via alternative mRNA splicing) to promote bladder cancer cell migration and invasion; overexpression of MEIS2-L rescues oncogenic migration/invasion abilities and MMP9 expression after PTBP1 knockdown.\",\n      \"method\": \"siRNA knockdown, splicing variant overexpression rescue experiments, in vitro migration/invasion assays, in vivo lymph node metastasis model\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — splice variant identified as functional effector by rescue experiment; single lab\",\n      \"pmids\": [\"30742945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MEIS2 is a substrate of the CRL4-cereblon (CRL4CRBN) E3 ubiquitin ligase; IMiDs block MEIS2 from binding CRBN, facilitating CRL4CRBN-IMiD E3-ubiquitin ligase activity and proteasome-mediated degradation of target substrates. MEIS2 also regulates Cyclin E/CCNE1 and NKG2D/DNAM-1 NK-cell ligand expression in multiple myeloma cells.\",\n      \"method\": \"siRNA knockdown, crystallographic identification of MEIS2-CRBN interaction (referenced), apoptosis and proliferation assays, BET inhibitor treatment\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — CRBN substrate identification from crystal structure (referenced), functional siRNA data; single lab for MM-specific functional studies\",\n      \"pmids\": [\"30975979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Silencing of both Rb1 and Meis2 by siRNA in adult cardiomyocytes promotes cell cycle re-entry; simultaneous knockdown results in increased proliferation markers (EdU, PH3, Ki67, Aurora B), reduced cardiomyocyte size, increased mononucleation, and improved cardiac function post-myocardial infarction in vivo, identifying Meis2 as a senescence-associated cell cycle inhibitor in cardiomyocytes.\",\n      \"method\": \"siRNA knockdown in isolated adult rat cardiomyocytes and hiPSC-derived cardiomyocytes, hydrogel-based in vivo delivery post-MI, immunofluorescence for proliferation markers, echocardiography\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function with defined proliferation phenotype in vitro and in vivo; combinatorial knockdown complicates attribution to Meis2 alone\",\n      \"pmids\": [\"31315484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MEIS2 directly binds chromatin of osteogenic gene loci (identified by ChIP-seq) and is required for chromatin accessibility of osteogenic genes (ATAC-seq) in the developing palate; MEIS2 physically interacts with SHOX2 and co-occupies osteogenic gene loci genome-wide. MEIS2 is required for palatal bone formation downstream of neural crest cell specification.\",\n      \"method\": \"Conditional KO mice (Wnt1-Cre), ChIP-seq, RNA-seq, ATAC-seq, Co-IP (MEIS2–SHOX2 interaction), rescue experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genome-wide ChIP-seq, ATAC-seq, RNA-seq plus Co-IP and genetic rescue; multiple orthogonal methods in a single study\",\n      \"pmids\": [\"32169905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Variant PRC1 incorporating PCGF3 and PCGF5 represses Meis2 in the distal forelimb bud; PcG factors and retinoic acid-related signals antagonize each other to polarize Meis2 expression along the proximal-distal axis, with PcG adjusting the threshold for RA signaling to regulate Meis2.\",\n      \"method\": \"Mouse genetics (conditional knockouts), mathematical modeling, ChIP, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and molecular dissection of PRC1 subunit specificity; modeling supplements experimental data\",\n      \"pmids\": [\"30190278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MEIS2 nuclear localization is regulated post-translationally; arginine methylation on a conserved residue close to nested CRM1- and PBX1-binding sites controls nuclear/cytoplasmic partitioning. In the adult V-SVZ, high calpain-2 activity in stem/progenitor cells cleaves MEIS2, and reduced calpain-2 activity during neuronal differentiation stabilizes MEIS2 full-length protein.\",\n      \"method\": \"Site-directed mutagenesis of arginine, Co-IP, fractionation; calpain-2 substrate identification by in vitro cleavage and mass spectrometry (described in 2024 paper but methylation result 2018)\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — PTM site mapped by mutagenesis, binding partner competition defined, nuclear export receptor interaction demonstrated\",\n      \"pmids\": [\"29641989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MEIS2 is a direct substrate of the intracellular protease calpain-2 (CAPN2/CAPNS1); phosphorylation at conserved serine/threonine residues or dimerization with PBX1 reduces MEIS2 sensitivity to calpain-2 cleavage. High calpain-2 activity in adult V-SVZ stem/progenitor cells degrades MEIS2, and its decline during differentiation allows MEIS2 full-length accumulation needed for neuronal fate. Blocking calpain-2 or expressing cleavage-insensitive MEIS2 increases neuron production.\",\n      \"method\": \"In vitro protease cleavage assay with recombinant calpain-2, mutagenesis of phosphorylation/dimerization sites, Co-IP, overexpression of catalytically active CAPN2, neuronal differentiation assays in adult V-SVZ\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro cleavage reconstitution, mutagenesis of regulatory sites, gain/loss-of-function with defined neurogenesis phenotype\",\n      \"pmids\": [\"38305737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Meis2 directly binds the Zfp503 and Six3 promoters and is required for their expression; Dlx1/2 drives Meis2 expression in LGE progenitors at least partly through the hs599 enhancer. Loss of Meis2 blocks striatal medium spiny neuron (MSN) differentiation, reducing D1 and D2 MSNs.\",\n      \"method\": \"Conditional KO mice (Meis2 deletion), ChIP to show direct promoter binding of Zfp503 and Six3, in situ hybridization, cell counting\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrates direct promoter binding, conditional KO with defined differentiation phenotype, genetic epistasis (Dlx1/2→Meis2→Zfp503/Six3)\",\n      \"pmids\": [\"35156680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Meis2 is specifically expressed in cutaneous low-threshold mechanoreceptors (LTMRs) in mice, dependent on target-derived signals. Conditional loss of Meis2 in LTMRs does not affect their survival or initial specification but markedly impairs end-organ innervation morphology, electrophysiological properties, and transcriptome, resulting in impaired light touch behavioral responses.\",\n      \"method\": \"Conditional KO mice (LTMR-specific), electrophysiology, electron/confocal microscopy of end-organ morphology, behavioral assays, transcriptome profiling\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean tissue-specific KO with multiple orthogonal readouts (morphology, electrophysiology, behavior, transcriptome)\",\n      \"pmids\": [\"38386003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Meis2 conditional inactivation in neural crest cells (Wnt1-Cre) causes loss of Sonic hedgehog (Shh) signaling in oropharyngeal epithelium, impaired patterning of the first pharyngeal arch along lateral-medial and oral-aboral axes, and hypoplastic tongue with ectopic mandibular ossification.\",\n      \"method\": \"Conditional KO mice (Wnt1-Cre;Meis2fl/fl), in situ hybridization, immunohistochemistry for Shh pathway components and pharyngeal arch markers\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined pathway (Shh) and morphological phenotype; single lab\",\n      \"pmids\": [\"32616504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Meis2 loss-of-function in the cochlea leads to a phenotype resembling Shh mutants, with loss of apically expressed cochlear genes and ectopic/extra rows of sensory hair cells; Meis2 ChIP-seq in an otic cell line identifies direct target genes involved in Shh-mediated cochlear patterning.\",\n      \"method\": \"Conditional KO mice, gene expression profiling, ChIP-seq in otic cell line\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq plus KO phenotype linking Meis2 to Shh pathway in cochlea; single lab\",\n      \"pmids\": [\"39351969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CDK4/6 inhibition rapidly accelerates IMiD-mediated displacement of MEIS2 from CRBN and destabilizes MEIS2 protein while increasing CRBN levels, enhancing CRL4CRBN ubiquitination of IKZF3/IKZF1 for degradation. MEIS2 also promotes BCMA expression and antagonizes BCMA repression by IMiD/CELMoD, providing a survival signal in myeloma cells.\",\n      \"method\": \"Biochemical displacement assays, protein stability assays, ubiquitination assays, Co-IP, cell viability and apoptosis assays in bone marrow myeloma cells\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic biochemical assays (Co-IP, ubiquitination) with functional readouts; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"41279046\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"OGT mediates O-GlcNAcylation of MEIS2 at serine 237, which maintains MEIS2 protein stability by inhibiting its ubiquitination; loss of O-GlcNAc in zebrafish results in elevated cleft palate prevalence and impaired palatal bone formation. O-GlcNAcylation of MEIS2 maintains osteogenic homeostasis in palatal development.\",\n      \"method\": \"Mass spectrometry identification of O-GlcNAcylation site, site-directed mutagenesis (Ser237), ubiquitination assay, zebrafish loss-of-function, protein stability assay\",\n      \"journal\": \"International journal of oral science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — PTM site identified by MS and confirmed by mutagenesis, mechanistic link (O-GlcNAc inhibits ubiquitination) demonstrated biochemically with in vivo validation\",\n      \"pmids\": [\"41936590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"LncRNA RMG regulates myogenesis by modulating liquid-liquid phase separation (LLPS) of MEIS2; lnc-RMG produces miR-133a-3p which targets and inhibits MEIS2 expression, thereby inhibiting MEIS2 LLPS. This inhibition promotes TGFβR2 transcription to regulate myogenesis.\",\n      \"method\": \"lncRNA knockdown, miRNA overexpression, LLPS assay for MEIS2, luciferase reporter, qPCR/western blot, skeletal muscle regeneration model\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — LLPS demonstrated but MEIS2 condensate biology mechanistically underdeveloped; single study\",\n      \"pmids\": [\"40252346\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MEIS2 is a TALE-homeodomain transcription factor that acts as a context-dependent transcriptional activator or repressor: it forms heterodimeric and trimeric complexes with PBX1 and HOX-class proteins (PDX1, Otx2, Pax3/7, Klf4) to regulate target gene transcription, is subject to multilayered post-translational regulation including arginine methylation (controlling nuclear export via CRM1), O-GlcNAcylation at Ser237 (stabilizing the protein by blocking ubiquitination), and calpain-2-mediated proteolytic cleavage (modulating its activity in neural stem/progenitor cells); its genomic locus is regulated by PRC1/RING1B-mediated chromatin topology and retinoic acid signaling to control proximal-distal limb patterning and midbrain specification, and it controls cell fate in multiple developmental contexts including striatal MSN differentiation (via direct transcription of Zfp503 and Six3), adult SVZ neurogenesis, neural crest-derived craniofacial and cardiac structures, and low-threshold mechanoreceptor maturation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MEIS2 is a TALE-class homeodomain transcription factor that functions as a context-dependent transcriptional activator by forming heterodimeric and trimeric complexes with PBX1, HOX-class proteins, and tissue-specific partners (Otx2, Pax3/7, Pax6, Dlx2, Klf4, SHOX2) to regulate target genes in diverse developmental and adult contexts including limb proximal-distal patterning, midbrain tectal specification, striatal medium spiny neuron differentiation, adult SVZ neurogenesis, craniofacial/cardiac neural crest morphogenesis, and low-threshold mechanoreceptor maturation [PMID:10619030, PMID:19736326, PMID:35156680, PMID:24284204, PMID:26545946, PMID:38386003]. Its transcriptional output is controlled by autoinhibition of its C-terminal activation domain by the Hth domain (relieved by PBX1 binding), competition with co-repressors such as Groucho/Tle4 and TGIF, and Polycomb (RING1B/PRC1)-dependent chromatin topology that gates locus activation in response to retinoic acid signaling [PMID:20553494, PMID:19736326, PMID:10764806, PMID:24374176, PMID:26674308]. MEIS2 protein abundance and nuclear accumulation are regulated by multilayered post-translational mechanisms: arginine methylation controls CRM1-dependent nuclear export, O-GlcNAcylation at Ser237 stabilizes MEIS2 by blocking ubiquitination, calpain-2-mediated proteolytic cleavage limits full-length protein in stem/progenitor cells, and MEIS2 serves as a substrate of the CRL4-CRBN E3 ubiquitin ligase displaced by immunomodulatory drugs [PMID:29641989, PMID:41936590, PMID:38305737, PMID:30975979]. MEIS2 directly activates genes including FOXM1, doublecortin, tyrosine hydroxylase, Zfp503, Six3, and osteogenic loci, and is required for chromatin accessibility at its target sites [PMID:25210800, PMID:24284204, PMID:35156680, PMID:32169905].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing MEIS2 as a transcription factor capable of trimeric complex formation with PBX and HOX-class partners answered how a TALE-homeodomain protein achieves tissue-specific transcriptional switching—here converting PDX1 from beta-cell to acinar-type activation.\",\n      \"evidence\": \"Co-IP, EMSA, and reporter assays reconstituting the MEIS2–PBX1b–PDX1 trimeric complex on the elastase I enhancer B element in pancreatic cell lines\",\n      \"pmids\": [\"9710595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trimeric complex demonstrated only on one enhancer element\", \"Structural basis for partner selectivity unknown\", \"In vivo relevance for pancreatic cell fate not tested genetically\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that Meis2 expression is restricted to proximal limb and that ectopic expression represses distal limb genes established MEIS2 as a spatial determinant of proximal-distal limb identity, a role later shown to be Polycomb-regulated.\",\n      \"evidence\": \"Ectopic Meis2 expression in chick limb bud with epistasis to BMPs and Hoxd genes; in situ hybridization\",\n      \"pmids\": [\"10619030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream targets in limb not identified at this stage\", \"Mechanism of BMP/Hoxd-mediated repression of Meis2 unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of MEIS2 isoforms activating the dopamine D1A receptor promoter, and competition by TGIF on the same DNA sites, revealed a splice-variant-based regulatory logic including dominant-negative inhibition by Meis2e.\",\n      \"evidence\": \"EMSA, reporter assays across multiple cell lines, and co-expression competition assays with TGIF and Meis2e\",\n      \"pmids\": [\"10764806\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts where Meis2e exerts dominant-negative function in vivo uncharacterized\", \"Full repertoire of direct DNA targets unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showing that Meis2 competes with the Groucho co-repressor Tle4 for Otx2 binding to relieve transcriptional repression defined the mechanism by which MEIS2 specifies tectal fate—functioning not solely as a DNA-binding activator but as a co-factor competition switch.\",\n      \"evidence\": \"In ovo electroporation gain/loss-of-function, reciprocal Co-IP competition assays, Otx2-dependent reporter\",\n      \"pmids\": [\"19736326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this competition mechanism operates in mammalian midbrain unknown\", \"Direct target genes downstream of Otx2-Meis2 in tectum not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that the Hth domain autoinhibits MEIS2's C-terminal activation domain and that PBX1 binding partially relieves this autoinhibition revealed an intrinsic regulatory switch gating transcriptional output on PBX dimerization.\",\n      \"evidence\": \"Domain deletion/mutation analysis with transcriptional reporter readouts; comparison with Meis3.2 splice variant\",\n      \"pmids\": [\"20553494\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for autoinhibition not resolved\", \"Whether other partners besides PBX1 relieve autoinhibition untested\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of a MEIS2–PBX1–KLF4 cooperative complex that activates p15(Ink4a) and E-cadherin expanded the partner repertoire beyond HOX-class proteins and linked MEIS2 to cell cycle control.\",\n      \"evidence\": \"Reciprocal Co-IP, reporter assays, siRNA knockdown with S-phase entry readout\",\n      \"pmids\": [\"21746878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this complex operates in normal development or only in tumor suppression unclear\", \"Genome-wide target landscape of MEIS2–KLF4 not mapped\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two concurrent advances established (i) a Meis2–Pax6–Dlx2 complex driving adult SVZ neurogenesis with direct ChIP-validated targets (doublecortin, tyrosine hydroxylase), and (ii) a RING1B-dependent chromatin topology mechanism (promoter–enhancer–RBS tripartite loop) gating Meis2 locus activation during midbrain development.\",\n      \"evidence\": \"(i) Retroviral dominant-negative and siRNA in vivo, ChIP, Co-IP in adult SVZ; (ii) 3C/4C, ChIP, conditional KO mice, transgenic reporters\",\n      \"pmids\": [\"24284204\", \"24374176\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the Pax6–Dlx2–Meis2 complex acts identically in embryonic and adult neurogenesis untested\", \"How RING1B release is triggered at the molecular level remains unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that MEIS2 directly drives FOXM1 and the MuvB–BMYB–FOXM1 mitotic gene program in neuroblastoma revealed a role for MEIS2 in M-phase progression beyond developmental transcription.\",\n      \"evidence\": \"siRNA depletion, ChIP on FOXM1 promoter, gene expression profiling, proliferation/tumorigenicity assays\",\n      \"pmids\": [\"25210800\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the FOXM1 axis is relevant in normal proliferating progenitors unknown\", \"MEIS2 co-factors in this context not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Conditional inactivation in neural crest cells causing persistent truncus arteriosus, craniofacial skeletal defects, and cranial nerve abnormalities, combined with epistasis showing RING1A/B represses Meis2 in distal limb, consolidated MEIS2 as essential for neural crest-derived tissue morphogenesis and confirmed Polycomb as a gate for Meis2 domain control in limb patterning.\",\n      \"evidence\": \"Neural crest-specific conditional KO mice (AP2α-Cre), Ring1A/B double KO with Meis2 rescue deletion, ChIP, in situ hybridization\",\n      \"pmids\": [\"26545946\", \"26674308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes mediating cardiac outflow tract septation not identified\", \"Whether MEIS2 acts cell-autonomously in all affected neural crest lineages not resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovery that arginine methylation on a conserved residue blocks CRM1-mediated nuclear export (without affecting PBX1 binding) introduced post-translational control of MEIS2 subcellular localization as a mechanism coupling EGFR signaling to neuronal differentiation, while variant PRC1 (PCGF3/5) was shown to set the RA-signaling threshold for Meis2 activation in limb.\",\n      \"evidence\": \"Site-directed mutagenesis, Co-IP of MEIS2–CRM1 and MEIS2–PBX1, cell fractionation, neuronal differentiation assay; PcG conditional KOs with mathematical modeling\",\n      \"pmids\": [\"29641989\", \"30190278\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the arginine methyltransferase responsible unknown\", \"How EGFR signaling controls methylation status not mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of MEIS2 as a CRL4-CRBN E3 ligase substrate displaced by immunomodulatory drugs (IMiDs) revealed a pharmacologically relevant degradation axis, while calpain-2 cleavage sensitivity—modulated by phosphorylation and PBX1 dimerization—provided a second proteolytic layer controlling MEIS2 levels in progenitor cells.\",\n      \"evidence\": \"Crystal structure reference for CRBN interaction, siRNA in myeloma cells; in vitro calpain-2 cleavage reconstitution (reported fully in 2024), mutagenesis of phosphorylation/dimerization sites\",\n      \"pmids\": [\"30975979\", \"38305737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of CRL4-CRBN vs. calpain-2 degradation in non-cancer contexts unresolved\", \"Calpain-2 cleavage site(s) not precisely mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Genome-wide ChIP-seq and ATAC-seq in the developing palate demonstrated that MEIS2 directly occupies and is required for chromatin accessibility at osteogenic gene loci, with SHOX2 as a physical co-occupant, providing the first genome-wide mechanistic view of MEIS2 chromatin function in craniofacial osteogenesis.\",\n      \"evidence\": \"Conditional KO mice (Wnt1-Cre), ChIP-seq, ATAC-seq, RNA-seq, Co-IP for MEIS2–SHOX2, rescue experiments\",\n      \"pmids\": [\"32169905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MEIS2 acts as a pioneer factor or requires pre-existing accessibility not tested\", \"SHOX2 contribution to co-occupied sites not dissected genetically\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstration that Meis2 directly binds Zfp503 and Six3 promoters and is required for striatal MSN differentiation, with Dlx1/2 acting upstream via the hs599 enhancer, established a complete genetic circuit for MEIS2-dependent ventral forebrain neuronal specification.\",\n      \"evidence\": \"Conditional KO mice, ChIP at Zfp503 and Six3 promoters, in situ hybridization, cell quantification\",\n      \"pmids\": [\"35156680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MEIS2 partners (PBX, Dlx) co-occupy these promoters in striatum not tested\", \"How D1 vs D2 MSN subtype specification diverges downstream of Meis2 unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Two studies extended MEIS2 biology to peripheral somatosensory neurons and to proteolytic regulation: Meis2 loss in LTMRs impaired end-organ innervation, electrophysiology, and touch behavior without affecting cell survival, while calpain-2 was biochemically reconstituted as a direct MEIS2 protease whose cleavage sensitivity is tuned by phosphorylation and PBX1 binding.\",\n      \"evidence\": \"LTMR-specific conditional KO with electrophysiology, EM, behavioral assays, transcriptomics; in vitro calpain-2 cleavage with recombinant proteins, mutagenesis, neuronal differentiation in adult V-SVZ\",\n      \"pmids\": [\"38386003\", \"38305737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target genes controlled by MEIS2 in LTMRs not validated by ChIP\", \"Whether calpain-2 regulation of MEIS2 operates beyond SVZ neurogenesis untested\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"O-GlcNAcylation at Ser237 was identified as a stabilizing modification that blocks MEIS2 ubiquitination, linking OGT activity to palatal bone formation and providing a third post-translational axis (alongside arginine methylation and calpain cleavage) controlling MEIS2 protein levels.\",\n      \"evidence\": \"Mass spectrometry for O-GlcNAc site, Ser237 mutagenesis, ubiquitination assay, zebrafish in vivo validation\",\n      \"pmids\": [\"41936590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Ser237 O-GlcNAcylation and CRL4-CRBN ubiquitination converge on the same lysine residues unknown\", \"OGT upstream signals in palatal mesenchyme not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the structural basis for MEIS2 partner selectivity across developmental contexts, the identity of the arginine methyltransferase controlling nuclear export, the precise calpain-2 cleavage site(s), genome-wide target landscapes in most tissues, and whether MEIS2 liquid-liquid phase separation has functional significance in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of MEIS2 in complex with any partner\", \"Arginine methyltransferase identity unknown\", \"Calpain-2 cleavage site(s) not mapped at residue level\", \"LLPS biology based on a single low-confidence study\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 3, 8, 10, 20, 24, 27]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 4, 6, 8, 10, 20, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [15, 22]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [15, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 4, 7, 8, 11, 12, 20, 24, 25, 26]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 3, 6, 10, 20, 24]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [9, 12, 21]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [15, 23, 29]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [8, 24, 25]}\n    ],\n    \"complexes\": [\n      \"MEIS2–PBX1 heterodimer\",\n      \"MEIS2–PBX1–PDX1 trimer\",\n      \"MEIS2–Pax6–Dlx2 complex\"\n    ],\n    \"partners\": [\n      \"PBX1\",\n      \"OTX2\",\n      \"PAX6\",\n      \"DLX2\",\n      \"KLF4\",\n      \"SHOX2\",\n      \"PAX3\",\n      \"CRBN\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}